Shares of IXICO plc (LON:IXI – Get Free Report) shot up 16.1% during trading on Tuesday. The stock traded as high as GBX 9.50 and last traded at GBX 9. 1,314,879 shares were traded during trading, an increase of 1,210% from the average session volume of 100,369 shares. The stock had previously closed at GBX 7.75.
IXICO Stock Performance
The company has a market cap of £19.71 million, a PE ratio of -4.62, a PEG ratio of -0.38 and a beta of 0.11. The company has a current ratio of 2.83, a quick ratio of 4.90 and a debt-to-equity ratio of 5.22. The business’s 50 day moving average is GBX 7.67 and its two-hundred day moving average is GBX 7.86.
IXICO Company Profile
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
Featured Stories
- Five stocks we like better than IXICO
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
- IonQ’s Bold Expansion Could Leave Shareholders Paying the Price
- Powering Up: Applied Digital Execs Buy $6.7M in Stock
- Chip Stocks Are Sliding—Why Is Smart Money Buying?
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
